These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 26589472)
1. Critical Review and Update on the Treatment of Acute and Chronic Pulmonary Embolism. Shapiro NL; Bhatt SH J Pharm Pract; 2016 Feb; 29(1):35-45. PubMed ID: 26589472 [TBL] [Abstract][Full Text] [Related]
2. Managing pulmonary embolism from presentation to extended treatment. Cohen AT; Dobromirski M; Gurwith MM Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642 [TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations. Prandoni P Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390 [TBL] [Abstract][Full Text] [Related]
4. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Hillis C; Crowther MA Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of life-threatening pulmonary embolism. Marshall PS; Mathews KS; Siegel MD J Intensive Care Med; 2011; 26(5):275-94. PubMed ID: 21606060 [TBL] [Abstract][Full Text] [Related]
6. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran. Leung TS; Law EH Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422 [TBL] [Abstract][Full Text] [Related]
7. Treatment strategies for acute pulmonary embolism. Blondon M; Bounameaux H; Righini M Expert Opin Pharmacother; 2009 May; 10(7):1159-71. PubMed ID: 19405790 [TBL] [Abstract][Full Text] [Related]
8. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations. van Es N; Büller HR Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711 [TBL] [Abstract][Full Text] [Related]
11. [The optimal duration of anticoagulant treatment following pulmonary embolism]. Couturaud F Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935 [TBL] [Abstract][Full Text] [Related]
12. Effective diagnosis and treatment of pulmonary embolism: Improving patient outcomes. Meyer G Arch Cardiovasc Dis; 2014; 107(6-7):406-14. PubMed ID: 25023859 [TBL] [Abstract][Full Text] [Related]
13. In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments. Lenchus JD; Biehl M; Cabrera J; Moraes AG; Dezfulian C J Intensive Care Med; 2017 Jun; 32(5):299-311. PubMed ID: 27179058 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and management of chronic pulmonary thromboembolic disease. Mendoza V; Scharf ML Hosp Pract (1995); 2011 Aug; 39(3):50-61. PubMed ID: 21881392 [TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants in the treatment of pulmonary embolism. Eldredge JB; Spyropoulos AC Curr Med Res Opin; 2018 Jan; 34(1):131-140. PubMed ID: 28771049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]